Use of an Antioxidant to prepare a Medicine to improve hemolysis associated with Ribavirin associated with Treatment of a viral infection susceptible to Ribavirin; as aFeccion of hepatitis C virus (HCV) Chronicle.

摘要

We describe methods to treat patients who have Viral Infections susceptibleEspecially the chronic hepatitis C infection by administering to the patient a therapeutically effective amount of a combination Therapy of interferon alpha and rivavirina during aTime enough to lower HCV - RNA associated with a therapeutically effective amount of an Antioxidant for a sufficient period to improve the hemolisisi relatedRibavirin.